Child and Adolescent Neuropsychopharmacology Network

Mission statement/aims

The Child and Adolescent Neuropsychopharmacology Network is concerned with setting the ground for development, implementation and education regarding neuropsychopharmacology in children and adolescents. Currently, there are major gaps in neuropsychopharmacological practice in minors, with lack of effective drugs for many childhood disorders and frequent off-label prescription to children and adolescents of medications with regulatory approval only in adults. The search for evidence-based approaches to prevent mental disorders with child- or adolescent-onset is also of main interest. There is need for better preclinical data to foster novel drug therapies and also of development of paediatric clinical trials in this challenging population.

Main activities are promoting knowledge about child and adolescence psychopharmacology among European young psychiatrists through the Venice School (initially once every two years and annual since 2014, click here for more info), writing grant applications to develop the field within European centres of excellence, and development of scientific publications. To foster development of paediatric clinical trials we also developed the European Child and Adolescent Clinical Psychopharmacology Network (ECACPN).


In 2008 the Executive Committee of the ECNP officially approved the formation of networks of researchers as part of the ECNP Networks initiative. The Child and Adolescent Neuropsychopharmacology Network, was created in the same year. This Network is an international multi-centre, independent collaborative cross-disciplinary research grouping currently including 32 scientists from 26 centres across 13 countries.